Athersys
ATHX
#10511
Rank
S$1.06 M
Marketcap
S$0.01723
Share price
-33.50%
Change (1 day)
-98.95%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -S$56.26 Million

According to Athersys's latest financial reports the company's current earnings are S$0.08 Million. In 2022 the company made an earning of -S$98.32 Million, an increase over its 2021 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$56.26 Million-42.78%
2022 -S$98.32 Million-11.54%
2021 -S$0.12 Billion11.14%
2020 -S$0.11 Billion72.2%
2019 -S$58.08 Million77.29%
2018 -S$32.76 Million-22.91%
2017 -S$42.5 Million111.89%
2016 -S$20.06 Million-8.52%
2015 -S$21.93 Million-40.81%
2014 -S$37.04 Million18.62%
2013 -S$31.23 Million
2011 -S$17.6 Million19.71%
2010 -S$14.7 Million-26.28%
2009 -S$19.94 Million-18.21%
2008 -S$24.38 Million-8.28%
2007 -S$26.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.35 B-77,672.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.13 B-28,479.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.52 B-19,840.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.61 B-21,890.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$29.47 B-55,389.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.25 B-19,335.19%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
S$0.21 B-496.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$4.02 Billion 7,430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.81 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA